Abstract
The activity of NF-κB/Rel nuclear factors is known to inhibit apoptosis in various cell types. We investigated whether the subtraction of NF-κB/Rel activity influenced the response of 11 AML (M1, M2 and M4) patients’ cells to AraC. To this end we used a phosphorothioate double-stranded decoy oligodeoxynucleotide (ODN) carrying the NF-κB/Rel− consensus sequence. Cell incubation with this ODN, but not its mutated (scrambled) form used as a control, resulted in abating the NF-κB/Rel nuclear levels in these cells, as verified by electrophoretic mobility shift assay (EMSA) of cells’ nuclear extracts. We incubated the leukemic cells with AraC (32 or 1 μM), in either the absence or presence of the decoy or the scrambled ODN, and analyzed cell apoptosis. The spontaneous cell apoptosis detectable in the absence of AraC (<25%) was not modulated by the oligonucleotide presence in cell cultures. on the other hand, in 10 of the 11 samples tested, the decoy κb, but not the scrambled odn significantly (p < 0.01 in a student's t test) enhanced cell apoptotic response to arac. such an effect was particularly remarkable at low arac doses (1 μM). These findings indicate that NF-κB/Rel activity influences response to AraC in human primary myeloblastic cells, and suggests that the inhibition of NF-κB/Rel factors can improve the effect of chemotherapy in AML.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Ghosh S, May MJ, Kopp EB . NF-κB and Rel proteins: evolutionary conserved mediators of immune response Annu Rev Immunol 1998 16: 225–260
Chen F, Castranova V, Shi X, Demers LM . New insights into the role of NF-κB, a ubiquitous transcription factor in the initiation of diseases Clin Chem 1999 45: 7–12
Beg AA, Baltimore D . An essential role for NF-κB in preventing TNF-α induced cell death Science 1996 274: 782–784
Wang C-I, Mayo MW, Baldwin AS Jr . TNF and cancer therapy induced apoptosis: potentiation by inhibition of NF-κB Science 1996 274: 784–787
Van Antwerp DJ et al. Suppression of TNF-α-induced apoptosis by NF-κB Science 1996 274: 787–789
Liu Z, Hsu H, Goeddel DV, Karin M . Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF-κB activation prevents cell death Cell 1996 87: 565–576
Romano MF et al. Triggering of CD40 antigen inhibits fludarabine-induced apoptosis in B chronic lymphocytic leukemia cells Blood 1998 92: 990–995
Van Antwerp DJ, Martin SJ, Verma IM, Green DR . Inhibition of TNF-induced apoptosis by NF-κB Trends Cell Biol 1998 8: 107–111
Wang CY, Cusack JC, Liu R, Baldwin AS Jr . Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB Nature Med 1999 5: 412–417
Zong WX, Bash J, Gelinas C . Rel blocks anti-Fas- and TNFα-induced apoptosis and intact Rel transactivation domain is essential for this effect Cell Death Differ 1998 5: 963–972
Bakker TR, Reed D, Renno T, Jongeneel CV . Efficient adenoviral transfer of NF-κB inhibitor sensitizes melanoma to tumor necrosis factor-mediated apoptosis Int J Cancer 1999 80: 320–323
Grumont RJ, Rourke IJ, Gerondakis S . Rel-dependent induction of A1 transcription is required to protect B cells from antigen receptor ligation-induced apoptosis Genes Dev 1999 13: 400–407
Zong W-X et al. The pro-survival Bcl-2 homolog Bfl-1/A1 is a direct transcriptional target of NF-κB that blocks TNFα-induced apoptosis Genes Dev 1999 13: 382–389
Chu ZL et al. Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control Proc Natl Acad Sci USA 1997 94: 10057–10061
Wang CY et al. NF-κB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation Science 1998 281: 1680–1683
Opipari AW Jr, Hu HM, Yabkowitz R, Dixit VM . The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity J Biol Chem 1992 267: 12424–12429
Wu MX et al. IEX-1L, an apoposis inhibitor involved in NF-κB-mediated cell survival Science 1998 281: 998–1001
Paillard F . Induction of apoptosis with IκB, the inhibitor of NF-κB Hum Gene Ther 1999 10: 1–3
Romano MF, Lamberti A, Turco MC, Venuta S . CD40 and B chronic lymphocytic leukemia cell response to fludarabine: the influence of NF-κB/Rel transcription factors on drug-induced apoptosis Leuk Lymphoma 2000 36: 255–262
Waddick KG, Uckun FM . Innovative treatment programs against cancer: II. NF-κB as a molecular target Biochem Pharmacol 1999 57: 9–15
Bielinska A, Shivdasani RA, Zhang L, Nabel GJ . Regulation of gene expression with double-stranded phosphorothioate oligonucleotides Science 1990 250: 997–1000
Sullenger BA, Gallardo HF, Ungers GE, Gilboa E . Overexpression of TAR sequence renders cells resistant to human immunodeficiency virus replication Cell 1990 63: 601–608
Morishita R et al. A novel molecular strategy using cis-element ‘decoy’ of E2F binding site inhibits smooth muscle proliferation in vivo Proc Natl Acad Sci USA 1995 92: 5855–5859
Morishita R et al. In vivo transfection of cis-element ‘decoy’ against NFκB binding site prevented myocardial infarction as gene therapy Nature Med 1997 3: 894–899
Kawamura I et al. Intratumoral injection of oligonucleotides to the NFκB binding site inhibits cachexia in a mouse tumor model Gene Therapy 1999 6: 91–97
Romano MF et al. Amifostine inhibits haematopoietic progenitor cell apoptosis by activating NF-κB/Rel transcription factors Blood 1999 94: 4060–4066
Goldring EP, Narayanan R, Lagadec P, Jeannin J-F . Transcriptional inhibition of the inducible nitric oxide synthase gene by competitive binding of NF-κB/Rel proteins Biochem Biophys Res Commun 1995 209: 73–78
Sharma HW et al. Transcription factors decoy approach to decipher the role of NF-κB in oncogenesis Anticancer Res 1996 16: 61–68
Khaled AR, Butfiloski EJ, Sobel ES, Schiffenbauer J . Use of phosphorothioate-modified oligodeoxynucleotides to inhibit NF-κB expression and lymphocyte function Clin Immunol Immunopathol 1998 86: 170–175
Romano MF et al. IL-10 inhibits nuclear factor-κB/Rel nuclear activity in CD3-stimulated human peripheral T lymphocytes J Immunol 1996 156: 2119–2125
Bargou RC et al. Constitutive nuclear factor-κB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells J Clin Invest 1997 12: 2961–2969
Sovak MA et al. Aberrant nuclear factor-κB/Rel expression and the pathogenesis of breast cancer J Clin Invest 1997 12: 2952–2960
Bishop MR et al. Phase I trial of an antisense oligonucleotide OL(1)p53 in hematologic malignancies J Clin Oncol 1996 14: 1320–1326
Webb A et al. BCL-2 antisense therapy in patients with non-Hodgkin lymphoma Lancet 1997 349: 1137–1141
Nicoletti I et al. A rapid and simple method for measuringthymocyte apoptosis by propidium iodide staining and flowcytometry J Immunol Meth 1991 139: 271–279
Acknowledgements
This work was partially supported by Italian AIRC, MURST and FSN. The excellent technical help of C Del Gaudio is acknowledged.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Romano, M., Lamberti, A., Bisogni, R. et al. Enhancement of cytosine arabinoside-induced apoptosis in human myeloblastic leukemia cells by NF-κB/Rel− specific decoy oligodeoxynucleotides. Gene Ther 7, 1234–1237 (2000). https://doi.org/10.1038/sj.gt.3301216
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301216
Keywords
This article is cited by
-
Oxidative resistance of leukemic stem cells and oxidative damage to hematopoietic stem cells under pro-oxidative therapy
Cell Death & Disease (2020)
-
Inhibition of intracellular dipeptidyl peptidases 8 and 9 enhances parthenolide’s anti-leukemic activity
Leukemia (2013)
-
Targeting NF-κB in hematologic malignancies
Cell Death & Differentiation (2006)
-
Mechanisms controlling pathogenesis and survival of leukemic stem cells
Oncogene (2004)
-
NF-κB/Rel-mediated regulation of apoptosis in hematologic malignancies and normal hematopoietic progenitors
Leukemia (2004)